{"hands_on_practices": [{"introduction": "The cornerstone of successful Thoracic Endovascular Aortic Repair (TEVAR) is precise stent-graft sizing. This requires translating complex, often non-circular aortic anatomy into a functional diameter for device selection. This practice [@problem_id:5193469] grounds you in the fundamental bioengineering principles of this process, using an equal-area approximation to determine the effective diameter of an elliptical aorta. By calculating the oversizing fraction, you will engage with the critical balance between achieving a durable seal to prevent endoleaks and mitigating the risk of iatrogenic aortic injury, a trade-off that differs significantly between aneurysmal disease and fragile aortic dissections.", "problem": "An adult patient is scheduled for Thoracic Endovascular Aortic Repair (TEVAR) for a degenerative descending thoracic aortic aneurysm. The proximal landing zone of the descending thoracic aorta is measured on electrocardiogram-gated computed tomography as having an elliptical inner lumen with minor axis $28.0$ mm and major axis $32.0$ mm at mid-diastole. A stent-graft with nominal diameter $34.0$ mm is being considered for implantation. Using a fundamental geometric equivalence principle (equal-area replacement of an ellipse by a circle) and the definition that stent-graft oversizing is the relative diameter difference between the selected stent-graft and the target aortic landing zone, compute the oversizing as a dimensionless fraction. Round your final result to four significant figures and report it without a percentage sign.\n\nIn your derivation, start from: (i) the area of an ellipse is $A=\\pi a b$, where $a$ and $b$ are the semi-axes, (ii) the area of a circle is $A=\\pi R^{2}$, and (iii) the definition of oversizing as the ratio of diameter difference to the aortic landing zone diameter. Then, using the thin-walled cylinder approximation for vessel mechanics with Laplaceâ€™s law ($\\sigma_{\\theta}=\\dfrac{P r}{t}$, where $\\sigma_{\\theta}$ is circumferential wall stress, $P$ is internal pressure, $r$ is radius, and $t$ is wall thickness), justify why appropriate target oversizing ranges differ between acute Stanford type B aortic dissection and degenerative thoracic aortic aneurysm, framing your explanation in terms of seal reliability versus iatrogenic injury risk. Your numerical answer must be only the oversizing fraction for the provided dimensions, rounded to four significant figures; the explanatory justification is qualitative and should not be included in the final numeric answer. Express any intermediate diameters in millimeters, but the final oversizing fraction must be unitless.", "solution": "The problem is validated as scientifically grounded, well-posed, objective, and internally consistent. It presents a standard bioengineering calculation relevant to cardiovascular device selection, followed by a request for a qualitative explanation based on established biomechanical principles. All necessary data and definitions are provided.\n\nThe first step is to calculate the effective diameter of the elliptical aortic lumen based on the principle of equal-area replacement. The givens are the minor axis diameter, $d_{minor} = 28.0$ mm, and the major axis diameter, $d_{major} = 32.0$ mm.\n\nThe semi-major axis, $a$, and semi-minor axis, $b$, are half of their respective major and minor axis diameters:\n$$a = \\frac{d_{major}}{2} = \\frac{32.0 \\, \\text{mm}}{2} = 16.0 \\, \\text{mm}$$\n$$b = \\frac{d_{minor}}{2} = \\frac{28.0 \\, \\text{mm}}{2} = 14.0 \\, \\text{mm}$$\n\nThe area of the elliptical lumen, $A_{ellipse}$, is given by the formula $A = \\pi a b$. Substituting the semi-axis values:\n$$A_{ellipse} = \\pi (16.0 \\, \\text{mm})(14.0 \\, \\text{mm}) = 224\\pi \\, \\text{mm}^2$$\n\nThis area is equated to the area of a circle, $A_{circle} = \\pi R_{aorta}^2$, where $R_{aorta}$ is the radius of the equivalent circular aorta. This value represents the radius of a circle that has the same cross-sectional area as the elliptical lumen.\n$$A_{circle} = A_{ellipse}$$\n$$\\pi R_{aorta}^2 = 224\\pi \\, \\text{mm}^2$$\nDividing both sides by $\\pi$ gives:\n$$R_{aorta}^2 = 224 \\, \\text{mm}^2$$\nThe equivalent radius is therefore:\n$$R_{aorta} = \\sqrt{224} \\, \\text{mm}$$\nThe effective diameter of the aortic landing zone, $D_{aorta}$, is twice the radius:\n$$D_{aorta} = 2 R_{aorta} = 2\\sqrt{224} \\, \\text{mm}$$\nTo simplify the radical, we find the largest perfect square factor of $224$: $224 = 16 \\times 14$.\n$$D_{aorta} = 2\\sqrt{16 \\times 14} \\, \\text{mm} = 2(4\\sqrt{14}) \\, \\text{mm} = 8\\sqrt{14} \\, \\text{mm}$$\nNumerically, $D_{aorta} \\approx 29.93325...$ mm.\n\nNext, we compute the oversizing. The nominal diameter of the selected stent-graft is given as $D_{stent} = 34.0$ mm. Oversizing is defined as the relative diameter difference between the stent-graft and the target aorta:\n$$\\text{Oversizing} = \\frac{D_{stent} - D_{aorta}}{D_{aorta}}$$\nSubstituting the values for $D_{stent}$ and $D_{aorta}$:\n$$\\text{Oversizing} = \\frac{34.0 - 8\\sqrt{14}}{8\\sqrt{14}}$$\nThis can be simplified to:\n$$\\text{Oversizing} = \\frac{34.0}{8\\sqrt{14}} - 1 = \\frac{17}{4\\sqrt{14}} - 1$$\nNow we compute the numerical value:\n$$\\text{Oversizing} \\approx \\frac{17}{4 \\times 3.741657} - 1 \\approx \\frac{17}{14.966629} - 1 \\approx 1.135865 - 1 = 0.135865$$\nThe problem requires rounding the final result to four significant figures.\n$$\\text{Oversizing} \\approx 0.1359$$\n\nThe second part of the problem requires a justification for why target oversizing ranges differ between degenerative thoracic aortic aneurysm and acute Stanford type B aortic dissection, using Laplace's law.\n\nLaplace's law for a thin-walled cylinder approximates the circumferential wall stress, $\\sigma_{\\theta}$, as:\n$$\\sigma_{\\theta} = \\frac{Pr}{t}$$\nwhere $P$ is the internal (blood) pressure, $r$ is the vessel radius, and $t$ is the wall thickness. When a stent-graft with a diameter larger than the native aorta is implanted, it exerts an outward radial force, increasing the aortic radius $r$ to match its own. This expansion induces tension in the aortic wall, which is quantified by the wall stress $\\sigma_{\\theta}$. A secure seal between the graft and the aortic wall depends on this radial force. However, excessive radial force can lead to iatrogenic injury.\n\nIn the case of a **degenerative thoracic aortic aneurysm**, the aortic wall is chronically diseased, often thickened and fibrotic, but it is structurally intact (not torn). The primary goal of TEVAR is to achieve a durable seal in the proximal and distal landing zones to exclude the aneurysm sac from circulation and prevent endoleaks (particularly type I, at the attachment sites). A moderate degree of oversizing (e.g., $15\\% - 25\\%$) is generally desired. This generates a substantial radial force, ensuring a robust and stable seal against the aortic wall, which can withstand hemodynamic forces over the long term and prevent graft migration. The risk of iatrogenic rupture is present but lower than in an acute dissection because the wall, although weak, is not acutely torn. The main priority is **seal reliability**.\n\nIn contrast, for an **acute Stanford type B aortic dissection**, the pathology is fundamentally different. There is an active tear in the inner layer (intima) of the aorta, allowing blood to enter and cleave the layers of the aortic wall, creating a false lumen. The tissue, particularly the intimal flap separating the true and false lumens, is exceedingly fragile. The goal of TEVAR here is to cover the entry tear, redirecting flow into the true lumen and promoting thrombosis and healing of the false lumen. According to Laplace's law, a large oversizing would significantly increase the radius $r$ and thus the circumferential stress $\\sigma_{\\theta}$ on an already acutely injured and delicate aortic wall. This high stress poses a severe risk of iatrogenic injury, such as creating a new tear, extending the dissection proximally into the arch (a catastrophic retrograde type A dissection), or causing an outright rupture of the thinned outer wall. Therefore, a much more conservative oversizing strategy (e.g., $5\\% - 15\\%$, or even less) is employed. The main priority shifts from maximizing seal force to **minimizing the risk of iatrogenic injury**. The radial force needs to be just sufficient to appose the graft and cover the tear without causing further damage to the fragile aortic structure.", "answer": "$$\\boxed{0.1359}$$", "id": "5193469"}, {"introduction": "Building upon the basic principles of oversizing, this exercise [@problem_id:5193454] introduces the common anatomical challenge of aortic taper, where the aorta narrows along its length. A single-diameter graft may be too loose distally or too tight proximally, compromising the repair. This problem simulates the clinical decision-making process of selecting an optimal tapered device from a list of available options, forcing you to work within specific, clinically relevant constraints for both proximal and distal landing zones and to optimize the choice by minimizing the mismatch in oversizing between the two ends.", "problem": "A patient with chronic type B aortic dissection is planned for Thoracic Endovascular Aortic Repair (TEVAR). High-resolution computed tomography angiography shows a proximal landing zone diameter of $30\\,\\text{mm}$ in the descending thoracic aorta just distal to the left subclavian artery and a distal landing zone diameter of $26\\,\\text{mm}$ immediately proximal to the visceral segment. To achieve secure fixation while minimizing the risk of distal stent-induced new entry tear and avoiding graft collapse in the narrowed true lumen, oversizing should be kept within conservative bounds at each landing zone.\n\nUse the following foundational definitions, which are widely accepted for endograft sizing:\n- The endograft oversizing fraction at a landing zone is defined by $\\text{OS} = \\dfrac{D_{\\text{device}}}{D_{\\text{native}}} - 1$, where $D_{\\text{device}}$ is the nominal endograft diameter at that end, and $D_{\\text{native}}$ is the measured native aortic diameter at the landing zone.\n- Define the oversizing mismatch as $\\Delta = \\left|\\text{OS}_{\\text{prox}} - \\text{OS}_{\\text{dist}}\\right|$.\n- For chronic dissection in non-aneurysmal landing zones, assume acceptable oversizing ranges of $0.05 \\leq \\text{OS}_{\\text{prox}} \\leq 0.15$ proximally and $0.00 \\leq \\text{OS}_{\\text{dist}} \\leq 0.10$ distally.\n\nYou have the following tapered thoracic stent-grafts available (listed as proximal diameter/distal diameter in $\\text{mm}$): $(30/26)$, $(32/28)$, $(34/28)$, $(34/30)$, and $(36/32)$. Select the device that minimizes $\\Delta$ subject to the oversizing constraints given above. Then, calculate the proximal and distal oversizing fractions for your selected device.\n\nExpress the proximal and distal oversizing as decimals (no percent sign), and round each value to four significant figures. Report your final answer as a row matrix $\\begin{pmatrix}\\text{OS}_{\\text{prox}} & \\text{OS}_{\\text{dist}}\\end{pmatrix}$.", "solution": "The problem statement has been critically validated and is deemed valid. It is scientifically grounded in the principles of endovascular device sizing, well-posed with clear objectives and constraints, and presented objectively. All necessary data are provided, and the problem structure allows for a unique, verifiable solution.\n\nThe objective is to select the optimal tapered thoracic stent-graft from a given list that minimizes the oversizing mismatch, $\\Delta$, while adhering to specified proximal and distal oversizing constraints.\n\nThe givens are:\n- Proximal native aortic diameter: $D_{\\text{native, prox}} = 30\\,\\text{mm}$\n- Distal native aortic diameter: $D_{\\text{native, dist}} = 26\\,\\text{mm}$\n- A list of available stent-grafts, denoted by (proximal diameter/distal diameter): $(30/26)$, $(32/28)$, $(34/28)$, $(34/30)$, and $(36/32)$.\n\nThe definitions and constraints are:\n- Oversizing fraction: $\\text{OS} = \\dfrac{D_{\\text{device}}}{D_{\\text{native}}} - 1$\n- Oversizing mismatch: $\\Delta = \\left|\\text{OS}_{\\text{prox}} - \\text{OS}_{\\text{dist}}\\right|$\n- Proximal oversizing constraint: $0.05 \\leq \\text{OS}_{\\text{prox}} \\leq 0.15$\n- Distal oversizing constraint: $0.00 \\leq \\text{OS}_{\\text{dist}} \\leq 0.10$\n\nWe shall now evaluate each available device.\n\n1.  **Device (30/26):** $D_{\\text{device, prox}} = 30\\,\\text{mm}$, $D_{\\text{device, dist}} = 26\\,\\text{mm}$.\n    - Proximal oversizing: $\\text{OS}_{\\text{prox}} = \\dfrac{30}{30} - 1 = 0$.\n    This value does not satisfy the constraint $0.05 \\leq \\text{OS}_{\\text{prox}} \\leq 0.15$. Therefore, this device is not a valid choice.\n\n2.  **Device (32/28):** $D_{\\text{device, prox}} = 32\\,\\text{mm}$, $D_{\\text{device, dist}} = 28\\,\\text{mm}$.\n    - Proximal oversizing: $\\text{OS}_{\\text{prox}} = \\dfrac{32}{30} - 1 = \\dfrac{2}{30} = \\dfrac{1}{15} \\approx 0.06667$.\n    This value satisfies the constraint $0.05 \\leq 0.06667 \\leq 0.15$.\n    - Distal oversizing: $\\text{OS}_{\\text{dist}} = \\dfrac{28}{26} - 1 = \\dfrac{2}{26} = \\dfrac{1}{13} \\approx 0.07692$.\n    This value satisfies the constraint $0.00 \\leq 0.07692 \\leq 0.10$.\n    - Since both constraints are met, this device is a valid candidate. The oversizing mismatch is:\n    $\\Delta = \\left|\\dfrac{1}{15} - \\dfrac{1}{13}\\right| = \\left|\\dfrac{13 - 15}{195}\\right| = \\dfrac{2}{195} \\approx 0.01026$.\n\n3.  **Device (34/28):** $D_{\\text{device, prox}} = 34\\,\\text{mm}$, $D_{\\text{device, dist}} = 28\\,\\text{mm}$.\n    - Proximal oversizing: $\\text{OS}_{\\text{prox}} = \\dfrac{34}{30} - 1 = \\dfrac{4}{30} = \\dfrac{2}{15} \\approx 0.1333$.\n    This value satisfies the constraint $0.05 \\leq 0.1333 \\leq 0.15$.\n    - Distal oversizing: $\\text{OS}_{\\text{dist}} = \\dfrac{28}{26} - 1 = \\dfrac{2}{26} = \\dfrac{1}{13} \\approx 0.07692$.\n    This value satisfies the constraint $0.00 \\leq 0.07692 \\leq 0.10$.\n    - Since both constraints are met, this device is also a valid candidate. The oversizing mismatch is:\n    $\\Delta = \\left|\\dfrac{2}{15} - \\dfrac{1}{13}\\right| = \\left|\\dfrac{26 - 15}{195}\\right| = \\dfrac{11}{195} \\approx 0.05641$.\n\n4.  **Device (34/30):** $D_{\\text{device, prox}} = 34\\,\\text{mm}$, $D_{\\text{device, dist}} = 30\\,\\text{mm}$.\n    - Proximal oversizing: $\\text{OS}_{\\text{prox}} = \\dfrac{34}{30} - 1 = \\dfrac{2}{15} \\approx 0.1333$. This is valid.\n    - Distal oversizing: $\\text{OS}_{\\text{dist}} = \\dfrac{30}{26} - 1 = \\dfrac{4}{26} = \\dfrac{2}{13} \\approx 0.1538$.\n    This value does not satisfy the constraint $0.00 \\leq \\text{OS}_{\\text{dist}} \\leq 0.10$. Therefore, this device is not a valid choice.\n\n5.  **Device (36/32):** $D_{\\text{device, prox}} = 36\\,\\text{mm}$, $D_{\\text{device, dist}} = 32\\,\\text{mm}$.\n    - Proximal oversizing: $\\text{OS}_{\\text{prox}} = \\dfrac{36}{30} - 1 = \\dfrac{6}{30} = \\dfrac{1}{5} = 0.2$.\n    This value does not satisfy the constraint $0.05 \\leq \\text{OS}_{\\text{prox}} \\leq 0.15$. Therefore, this device is not a valid choice.\n\nComparing the valid candidates:\n- Device $(32/28)$: $\\Delta \\approx 0.01026$\n- Device $(34/28)$: $\\Delta \\approx 0.05641$\n\nThe device that minimizes the oversizing mismatch $\\Delta$ is the $(32/28)$ graft. We now calculate the final oversizing fractions for this device, rounded to four significant figures.\n\nFor the selected device $(32/28)$:\n- Proximal oversizing fraction:\n$\\text{OS}_{\\text{prox}} = \\dfrac{1}{15} \\approx 0.066666...$\nRounding to four significant figures gives $0.06667$.\n\n- Distal oversizing fraction:\n$\\text{OS}_{\\text{dist}} = \\dfrac{1}{13} \\approx 0.076923...$\nRounding to four significant figures gives $0.07692$.\n\nThe final answer is composed of these two values.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.06667 & 0.07692\n\\end{pmatrix}\n}\n$$", "id": "5193454"}, {"introduction": "Effective TEVAR extends beyond anatomical device fitting to encompass vigilant post-procedural physiological management. One of the most feared complications is spinal cord ischemia, which is directly related to inadequate Spinal Cord Perfusion Pressure ($SCPP$). This practice [@problem_id:5193496] shifts focus to hemodynamic optimization, using a defined (though hypothetical) risk-cost model to balance the use of vasopressors and lumbar drainage. By solving this constrained optimization problem, you will develop a quantitative understanding of the clinical trade-offs involved in achieving a target $SCPP$ while minimizing the burdens and risks of the interventions themselves.", "problem": "A patient undergoing Thoracic Endovascular Aortic Repair (TEVAR) is managed to prevent spinal cord ischemia by manipulating Mean Arterial Pressure (MAP) and Cerebrospinal Fluid (CSF) pressure via vasopressors and lumbar drainage. Define Spinal Cord Perfusion Pressure (SCPP) as $SCPP = MAP - CSF$. Consider an adult patient whose baseline values are $MAP = 75$ mmHg and $CSF = 15$ mmHg immediately post-deployment. Assume a simple hemodynamic model in which spinal cord blood flow $Q_{\\text{sc}}$ is proportional to the perfusion gradient across the spinal cord, that is $Q_{\\text{sc}} \\propto SCPP$, with effective vascular resistance treated as constant over the range of interest.\n\nPost-TEVAR, the clinical objective is to ensure adequate spinal cord perfusion with a minimum perfusion pressure threshold $SCPP_{\\min} = 75$ mmHg. Let the management consist of increasing $MAP$ by a nonnegative increment $\\Delta MAP \\geq 0$ using vasopressors and decreasing $CSF$ by a nonnegative increment $\\Delta CSF \\geq 0$ using lumbar drainage. To reflect risk trade-offs, suppose the cumulative management burden (risk/cost) is modeled by the quadratic function $C(\\Delta MAP, \\Delta CSF) = k(\\Delta MAP)^{2} + h(\\Delta CSF)^{2}$, where $k = 1$ and $h = 2$, and the target condition is enforced as a hard constraint $SCPP_{\\text{baseline}} + \\Delta MAP + \\Delta CSF = SCPP_{\\min}$.\n\nStarting from the base definitions and the optimization framework described, compute the baseline $SCPP$ and determine, by minimizing $C(\\Delta MAP, \\Delta CSF)$ subject to the perfusion constraint, the optimal post-TEVAR $MAP$ target. Express the final answer as the single numerical value of the optimal target $MAP$ in mmHg. Round your answer to four significant figures and express it in mmHg.", "solution": "The problem will first be validated according to the specified criteria.\n\n### Step 1: Extract Givens\nThe data, variables, and conditions explicitly provided in the problem statement are:\n- Definition of Spinal Cord Perfusion Pressure (SCPP): $SCPP = MAP - CSF$.\n- Baseline Mean Arterial Pressure (MAP): $MAP_{\\text{baseline}} = 75$ mmHg.\n- Baseline Cerebrospinal Fluid (CSF) pressure: $CSF_{\\text{baseline}} = 15$ mmHg.\n- Proportionality of spinal cord blood flow: $Q_{\\text{sc}} \\propto SCPP$.\n- Minimum SCPP threshold: $SCPP_{\\min} = 75$ mmHg.\n- Increment to MAP: $\\Delta MAP \\geq 0$.\n- Decrement to CSF (expressed as a nonnegative increment): $\\Delta CSF \\geq 0$. The new CSF pressure is $CSF_{\\text{baseline}} - \\Delta CSF$.\n- Cumulative management burden (cost function): $C(\\Delta MAP, \\Delta CSF) = k(\\Delta MAP)^{2} + h(\\Delta CSF)^{2}$.\n- Cost function coefficients: $k = 1$ and $h = 2$.\n- Perfusion constraint: $SCPP_{\\text{baseline}} + \\Delta MAP + \\Delta CSF = SCPP_{\\min}$.\n- The final answer is required to be rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity:\n- **Scientifically Grounded:** The physiological concepts ($MAP$, $CSF$, $SCPP$) and the relationship $SCPP = MAP - CSF$ are fundamental principles in cardiovascular and neurological physiology. The management strategies (vasopressors for $MAP$, lumbar drainage for $CSF$) are standard clinical practice. The hemodynamic model $Q_{\\text{sc}} \\propto SCPP$ is a direct application of Ohm's law for fluid flow ($\\text{Flow} = \\frac{\\Delta \\text{Pressure}}{\\text{Resistance}}$), a valid simplification. The cost function is an explicitly stated mathematical model for risk, which is a common approach in optimization problems. The given physiological values are within a realistic range for a post-surgical patient. The problem is scientifically grounded.\n- **Well-Posed:** The task is to minimize a convex quadratic function $C(\\Delta MAP, \\Delta CSF) = (\\Delta MAP)^{2} + 2(\\Delta CSF)^{2}$ subject to a linear constraint $\\Delta MAP + \\Delta CSF = \\text{constant}$ and non-negativity constraints $\\Delta MAP \\geq 0, \\Delta CSF \\geq 0$. This is a standard convex optimization problem, which guarantees the existence of a unique minimum. Therefore, the problem is well-posed.\n- **Objective:** The problem is formulated with precise mathematical definitions, quantitative data, and a clear, unambiguous objective. It is free of subjective or opinion-based statements.\n- **Completeness and Consistency:** All necessary information is provided. The definitions and constraints are internally consistent. For instance, the stated constraint $SCPP_{\\text{baseline}} + \\Delta MAP + \\Delta CSF = SCPP_{\\min}$ is consistent with the definitions of the new pressures: $MAP_{\\text{new}} = MAP_{\\text{baseline}} + \\Delta MAP$ and $CSF_{\\text{new}} = CSF_{\\text{baseline}} - \\Delta CSF$, which gives $SCPP_{\\text{new}} = MAP_{\\text{new}} - CSF_{\\text{new}} = (MAP_{\\text{baseline}} - CSF_{\\text{baseline}}) + \\Delta MAP + \\Delta CSF = SCPP_{\\text{baseline}} + \\Delta MAP + \\Delta CSF$. Setting $SCPP_{\\text{new}} = SCPP_{\\min}$ yields the given constraint.\n\n### Step 3: Verdict and Action\nThe problem is scientifically grounded, well-posed, objective, and internally consistent. It is deemed **valid**. A solution will be provided.\n\n### Solution Derivation\nThe objective is to find the optimal $\\Delta MAP$ and $\\Delta CSF$ that minimize the cost function $C(\\Delta MAP, \\Delta CSF)$ subject to the given constraint, and then to compute the resulting target $MAP$.\n\nFirst, calculate the baseline Spinal Cord Perfusion Pressure ($SCPP_{\\text{baseline}}$):\n$$SCPP_{\\text{baseline}} = MAP_{\\text{baseline}} - CSF_{\\text{baseline}} = 75 - 15 = 60 \\text{ mmHg}$$\n\nThe perfusion constraint is given by:\n$$SCPP_{\\text{baseline}} + \\Delta MAP + \\Delta CSF = SCPP_{\\min}$$\nSubstituting the known values $SCPP_{\\text{baseline}} = 60$ and $SCPP_{\\min} = 75$:\n$$60 + \\Delta MAP + \\Delta CSF = 75$$\nThis simplifies to the linear constraint equation:\n$$\\Delta MAP + \\Delta CSF = 15$$\n\nThe cost function to be minimized is:\n$$C(\\Delta MAP, \\Delta CSF) = k(\\Delta MAP)^{2} + h(\\Delta CSF)^{2}$$\nWith $k=1$ and $h=2$, this becomes:\n$$C(\\Delta MAP, \\Delta CSF) = (\\Delta MAP)^{2} + 2(\\Delta CSF)^{2}$$\n\nThis is a constrained optimization problem. We can solve it using the method of Lagrange multipliers. The Lagrangian function $\\mathcal{L}$ is defined as:\n$$\\mathcal{L}(\\Delta MAP, \\Delta CSF, \\lambda) = C(\\Delta MAP, \\Delta CSF) - \\lambda(\\Delta MAP + \\Delta CSF - 15)$$\n$$\\mathcal{L}(\\Delta MAP, \\Delta CSF, \\lambda) = (\\Delta MAP)^{2} + 2(\\Delta CSF)^{2} - \\lambda(\\Delta MAP + \\Delta CSF - 15)$$\n\nTo find the minimum, we compute the partial derivatives of $\\mathcal{L}$ with respect to $\\Delta MAP$, $\\Delta CSF$, and $\\lambda$, and set them to zero:\n1. $\\frac{\\partial \\mathcal{L}}{\\partial (\\Delta MAP)} = 2(\\Delta MAP) - \\lambda = 0 \\implies \\lambda = 2(\\Delta MAP)$\n2. $\\frac{\\partial \\mathcal{L}}{\\partial (\\Delta CSF)} = 4(\\Delta CSF) - \\lambda = 0 \\implies \\lambda = 4(\\Delta CSF)$\n3. $\\frac{\\partial \\mathcal{L}}{\\partial \\lambda} = -(\\Delta MAP + \\Delta CSF - 15) = 0 \\implies \\Delta MAP + \\Delta CSF = 15$\n\nFrom the first two equations, we can equate the expressions for $\\lambda$:\n$$2(\\Delta MAP) = 4(\\Delta CSF)$$\n$$\\Delta MAP = 2(\\Delta CSF)$$\n\nNow, substitute this relationship into the constraint equation (the third derivative equation):\n$$2(\\Delta CSF) + \\Delta CSF = 15$$\n$$3(\\Delta CSF) = 15$$\n$$\\Delta CSF = 5$$\n\nUsing this result, we find the optimal $\\Delta MAP$:\n$$\\Delta MAP = 2(\\Delta CSF) = 2(5) = 10$$\n\nThe solution $(\\Delta MAP, \\Delta CSF) = (10, 5)$ satisfies the non-negativity constraints $\\Delta MAP \\geq 0$ and $\\Delta CSF \\geq 0$.\n\nThe problem asks for the optimal post-TEVAR $MAP$ target. This is the new value of $MAP$ after the optimal increment $\\Delta MAP$ has been applied to the baseline value:\n$$MAP_{\\text{target}} = MAP_{\\text{baseline}} + \\Delta MAP$$\nSubstituting the values $MAP_{\\text{baseline}} = 75$ mmHg and the calculated optimal $\\Delta MAP = 10$ mmHg:\n$$MAP_{\\text{target}} = 75 + 10 = 85$$\n\nThe resulting value is $85$. The problem requires the answer to be rounded to four significant figures. Thus, the value $85$ is written as $85.00$.\nThe optimal target $MAP$ is $85.00$ mmHg.", "answer": "$$\n\\boxed{85.00}\n$$", "id": "5193496"}]}